ITPKB and neoplasm: Although no significant changes in PI3K signaling in B cells have been reported in Itpkb−/− mice, it is attractive to speculate that Itpkb or redundant IP3 3-kinases could have tumor-suppressor functions by dampening PI3K signaling through IP4/PIP3 antagonism.